Nevertheless, in a more recent publication by Gounder et al. that reported on the genetic testing results of more than 7000 sarcoma patients treated at Memorial Sloan Kettering Cancer Center, most were in cell cycle regulator genes, such as TP53, RB1, and CDKN2A [25]. Here, CDKN2A is linked to sarcoma.